These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 37594111)
1. WITHDRAWN: Validation of Novel Catechol Derivatives as Potent Escherichia coli MetAP Inhibitors Using Molecular Docking and Molecular Dynamics Simulation. Chowdhury A; Laskar MA; Panda D; Choudhury MD Comb Chem High Throughput Screen; 2024 May; ():. PubMed ID: 37594111 [TBL] [Abstract][Full Text] [Related]
2. WITHDRAWN: Anti-lung Cancer Mechanism of Hedyotis Diffusa Willd Based on Network Pharmacology and Molecular Docking. Huang F; Xu L; Niu W; Pang J; Li S; Li X Comb Chem High Throughput Screen; 2022 Aug; ():. PubMed ID: 36043773 [TBL] [Abstract][Full Text] [Related]
3. WITHDRAWN: Covid-19 Study, Pathology and Therapeutics. Lu DY Infect Disord Drug Targets; 2022 Feb; ():. PubMed ID: 35168512 [TBL] [Abstract][Full Text] [Related]
4. Withdrawal Notice: Community-wide Screening of Symptomatic and Asymptomatic Infection of Mycobacterium tuberculosis in the Saharia tribe of India. Singh P; Kumar R; Das A Comb Chem High Throughput Screen; 2021 Aug; ():. PubMed ID: 34382518 [TBL] [Abstract][Full Text] [Related]
5. WITHDRAWN: Design and Discovery of Lophine Derivatives as Multitargeting Agents by Molecular Docking, ADMET, MD Simulation and Pharmacophore Analysis: A Computational Approach. Kumar Biswas S; Sasmal P; Koley A; Jana R; Biswas J Comb Chem High Throughput Screen; 2023 Mar; ():. PubMed ID: 36959130 [TBL] [Abstract][Full Text] [Related]
6. WITHDRAWN: Original Antigenic Sin in COVID-19: Hoskins Effect and Vaccine. Khan M; Manzoor S; Ullah N; Khan D Infect Disord Drug Targets; 2022 Mar; ():. PubMed ID: 35301955 [TBL] [Abstract][Full Text] [Related]
7. WITHDRAWN: Rap2A/p-ERK1/2 is Involved in Glioma Proliferation and Migration. Wang T; Wang J; Liang R; He J; Liao Q; Jiang Y Curr Mol Med; 2022 Aug; ():. PubMed ID: 35927807 [TBL] [Abstract][Full Text] [Related]
8. WITHDRAWN: Application of Nanoparticles in the Management of Polycystic Ovary Syndrome. Al-Hetty HRAK; Saleh MM; Jalil AT Curr Drug Res Rev; 2023 Aug; ():. PubMed ID: 37592786 [TBL] [Abstract][Full Text] [Related]
9. WITHDRAWN: Computational Chemistry in the Fight Against SARSCoV-2. Khan A; Wei DQ Comb Chem High Throughput Screen; 2022 Jan; ():. PubMed ID: 35021969 [TBL] [Abstract][Full Text] [Related]
10. WITHDRAWN: Long-time-released Transdermal Microneedle Delivery System. Tang X; Qin H; Zhang X; Yang H; Yang J; Chen P; Jin Y; Yang L Curr Drug Deliv; 2023 Nov; ():. PubMed ID: 38018188 [TBL] [Abstract][Full Text] [Related]
11. Withdrawn: Camel FGF21 Protein Enhances FGF21 Signaling and its Targeted Compounds Screening. Gao Y; Yong F; Ji W; Zhang L; Hou J; Ma R; Zhao S; Ge H; Wu X Curr Pharm Des; 2024 Sep; ():. PubMed ID: 39350558 [TBL] [Abstract][Full Text] [Related]
12. Withdrawal Notice: Dietary Fatty Acids-effects on Cardiovascular Disease. Khorassani JK; Khorassani SK; Afshari A; Rezayi M; Langari H; Ghayour-Mobarhan M Mini Rev Med Chem; 2019 Sep; ():. PubMed ID: 31538894 [TBL] [Abstract][Full Text] [Related]
13. Withdrawal Notice: Antioxidant Effects of Polysaccharides from Traditional Chinese Medicines. Liu Y; Huang G Mini Rev Med Chem; 2017 Dec; ():. PubMed ID: 29219054 [TBL] [Abstract][Full Text] [Related]
14. WITHDRAWN: Dulaglutide Alleviates Alzheimer's Disease by Regulating Microglial Polarization and Neurogenic Activity. Wang Y; Han B Comb Chem High Throughput Screen; 2022 Jul; ():. PubMed ID: 35894460 [TBL] [Abstract][Full Text] [Related]
15. WITHDRAWN: Pharmaceutical Nanoemulsion System: A Strategy to Enhance the Bioavailability of Drugs. Kumar S; Waliyan P; Pahwa R; Ali J; Baboota S; Sharma S; Hyder Pottoo F Curr Drug Metab; 2022 Jun; ():. PubMed ID: 35786182 [TBL] [Abstract][Full Text] [Related]
16. Withdrawal Notice: Novel Pickering Emulsion Approach to Restrain Cancer Predicament. Singh SK; Baghel YS; Bhattacharya S Mini Rev Med Chem; 2020 Sep; ():. PubMed ID: 32875984 [TBL] [Abstract][Full Text] [Related]
17. Withdrawal Notice: Atrial Fibrillation and Hypertension: “Quo Vadis”. Walker M; Patel P; Kwon O; Koene RJ; Duprez DA; Kwon Y Curr Hypertens Rev; 2019 May; ():. PubMed ID: 31057122 [TBL] [Abstract][Full Text] [Related]
18. WITHDRAWN: In-Silico Study of Resveratrol as Multi-Edged Potent Inhibitor against SARSCov- 2 and Variants of Concern Using Molecular Dynamic Simulation and PCA Analysis. Singh V; Agarwal V; Varadwaj PK; Kumar Sahoo A Curr Pharm Des; 2022 Dec; ():. PubMed ID: 36537601 [TBL] [Abstract][Full Text] [Related]
19. WITHDRAWN: Green Synthesis and Evaluation of the Biological Activity of New Dihydropyridine Derivatives. Motamed NK; Larijani K; Pournamdari E; Saeidian H; Hargalani FZ Comb Chem High Throughput Screen; 2024 Jun; ():. PubMed ID: 38879776 [TBL] [Abstract][Full Text] [Related]